메뉴 건너뛰기




Volumn 207, Issue 2 SUPPL., 2005, Pages 679-683

Global gene mining and the pharmaceutical industry

Author keywords

Ethical issues; Gene mining; Pharmacogenetics

Indexed keywords

CLINICAL PROTOCOL; CONFERENCE PAPER; DRUG INDUSTRY; GENE CONTROL; GENE TARGETING; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GENETIC VARIABILITY; INFORMED CONSENT; MEDICAL DECISION MAKING; MEDICAL ETHICS; MEDICAL INFORMATION; MEDICAL SOCIETY; PHARMACOGENETICS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 24644497763     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2004.11.031     Document Type: Conference Paper
Times cited : (9)

References (11)
  • 1
    • 0003663231 scopus 로고
    • Oxford University Press, New York and Oxford. EMEA position paper on terminology in pharmacogenetics EMEA/CPMP 3070/01.
    • Beauchamp, T.L., Childress, J.F., 1994. Principles of biomedical ethics 4th edn. Oxford University Press, New York and Oxford. EMEA position paper on terminology in pharmacogenetics EMEA/CPMP 3070/01.
    • (1994) Principles of Biomedical Ethics 4th Edn.
    • Beauchamp, T.L.1    Childress, J.F.2
  • 3
    • 77953435763 scopus 로고    scopus 로고
    • Guidance for industry: Pharmacogenomic data submissions, draft guideline
    • Docket No 2003-0497
    • FDA, 2003. Guidance for industry: pharmacogenomic data submissions, draft guideline[Docket No 2003-0497, 68 Federal Register, 62461-62463].
    • (2003) Federal Register , vol.68 , pp. 62461-62463
  • 4
    • 4544335062 scopus 로고    scopus 로고
    • Ethical, social and legal implications of pharmacogenetics
    • L.E. Knudsen Ethical, social and legal implications of pharmacogenetics BioForum Eur. 6 2003 319 321
    • (2003) BioForum Eur. , vol.6 , pp. 319-321
    • Knudsen, L.E.1
  • 5
    • 0033806483 scopus 로고    scopus 로고
    • Regulatory aspects of the application of pharmacogenetics in drug discovery and development in Europe
    • L.E. Knudsen, and J. Renneberg Regulatory aspects of the application of pharmacogenetics in drug discovery and development in Europe Good Clin. Pract. 7 6 2000 11 13
    • (2000) Good Clin. Pract. , vol.7 , Issue.6 , pp. 11-13
    • Knudsen, L.E.1    Renneberg, J.2
  • 8
    • 0035469048 scopus 로고    scopus 로고
    • Family consent and the pursuit of better medicines through genetic research
    • G. Renegar, P. Rieser, and P. Manasco Family consent and the pursuit of better medicines through genetic research J. Contin. Educ. Health Prof. 21 2001 265 270
    • (2001) J. Contin. Educ. Health Prof. , vol.21 , pp. 265-270
    • Renegar, G.1    Rieser, P.2    Manasco, P.3
  • 9
    • 0010334847 scopus 로고    scopus 로고
    • Regulatory requirements for inclusion of pharmacogenetic testing in applications for clinical trials in Europe
    • M.D. Theilade, L.E. Knudsen, and J. Renneberg Regulatory requirements for inclusion of pharmacogenetic testing in applications for clinical trials in Europe Regul. Aff. J. 12 2 2001 92 99
    • (2001) Regul. Aff. J. , vol.12 , Issue.2 , pp. 92-99
    • Theilade, M.D.1    Knudsen, L.E.2    Renneberg, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.